Clinical Trial Update: CKD-841 Pharmacokinetic/Pharmacodynamic Study [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic/pharmacodynamic study of CKD-841 in postmenopausal disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Disorder

Drugs mentioned

• CKD-841

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Postmenopausal Disorder | Phase 1 | Status: COMPLETED